| アイテムタイプ |
学術雑誌論文 / Journal Article(1) |
| 公開日 |
2024-05-02 |
| タイトル |
|
|
タイトル |
External validation of the Candiolo nomogram for high-risk prostate cancer patients treated with carbon ion radiotherapy plus androgen deprivation therapy: a retrospective cohort study. |
|
言語 |
en |
| 言語 |
|
|
言語 |
eng |
| 資源タイプ |
|
|
資源タイプ識別子 |
http://purl.org/coar/resource_type/c_6501 |
|
資源タイプ |
journal article |
| 著者 |
Takanobu Utsumi
Hiroyoshi Suzuki
Hitoshi Ishikawa
Yuichi Hiroshima
Masaru Wakatsuki
Masaoki Harada
Tomohiko Ichikawa
Koichiro Akakura
Hiroshi Tsuji
|
| 抄録 |
|
|
内容記述タイプ |
Abstract |
|
内容記述 |
The aim of this study was to reclassify high-risk prostate cancer patients treated with carbon-ion radiotherapy and androgen deprivation therapy using the Candiolo nomogram and evaluate usefulness to predict the following 10-year biochemical recurrence. Six hundred seventy-two high-risk prostate cancer patients were reclassified according to the Candiolo nomogram. The cumulative incidence curves for biochemical recurrence were compared by Gray's test. Furthermore, five predictors of the Candiolo nomogram in our patients were evaluated by Fine and Gray regression hazards model. The higher the Candiolo risk, the worse the biochemical recurrence, especially in high- and very high-risk patients. Out of five predictors, age??70?years, cT3 stage, biopsy Gleason score??9 or the percentage of positive biopsy cores ?50% had significant impacts on 10-year biochemical recurrence in our patients. The Candiolo nomogram can reclassify our high-risk prostate cancer patients treated with carbon-ion radiotherapy and androgen deprivation therapy and evaluate the biochemical recurrence preciously. |
| 書誌情報 |
Japanese journal of clinical oncology
巻 52,
号 8,
p. 950-953,
発行日 2022-04
|
| 出版者 |
|
|
出版者 |
Oxford University Press |
| ISSN |
|
|
収録物識別子タイプ |
ISSN |
|
収録物識別子 |
1465-3621 |
| PubMed番号 |
|
|
|
識別子タイプ |
PMID |
|
|
関連識別子 |
35462397 |
| DOI |
|
|
|
識別子タイプ |
DOI |
|
|
関連識別子 |
10.1093/jjco/hyac066 |
